XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2019
Significant Accounting Policies  
Schedule of Bad Debt Expense

 

 

 

 

 

 

 

 

    

2018

    

2017

Bad debt expense

 

$

13,000

 

$

234,000

 

Property and Equipment

 

 

 

Computer equipment and software

    

3‑4 years

Office equipment

 

5 years

Office furniture and fixtures

 

7 years

Leasehold improvements

 

Term of lease or estimated useful life, whichever is shorter

 

Schedule of Capitalized Software Development Costs

 

 

 

 

 

 

 

 

 

Fiscal Year

 

    

2018

    

2017

Amortization expense on internally-developed software included in:

 

 

 

 

 

 

Cost of systems sales

 

$

768,000

 

$

1,914,000

Cost of software as a service

 

 

379,000

 

 

186,000

Cost of audit services

 

 

13,000

 

 

13,000

Total amortization expense on internally-developed software

 

$

1,160,000

 

$

2,113,000

 

Fair Value of Liabilities on a Recurring Basis

 

    

 

    

Quoted Prices in

    

Significant Other

    

Significant

 

 

Total Fair

 

Active Markets

 

Observable Inputs

 

Unobservable Inputs

 

 

Value

 

(Level 1)

 

 (Level 2)

 

(Level 3)

At January 31, 2019

 

 

  

 

 

  

 

 

  

 

 

  

Royalty liability (1) (3)

 

$

905,000

 

$

 —

 

$

 —

 

$

905,000

 

 

 

 

 

 

 

 

 

 

 

 

 

At January 31, 2018

 

 

  

 

 

  

 

 

  

 

 

  

Royalty liability (1) (2)

 

$

2,469,000

 

$

 —

 

$

 —

 

$

2,469,000


(1)

The initial fair value of royalty liability was determined by management with the assistance of an independent third-party valuation specialist, and by management thereafter. Fair value adjustments are included within miscellaneous expense in the consolidated statements of operations.

(2)

The fair value of the royalty liability was determined based on the probability-weighted revenue scenarios for the Streamline Health® Clinical Analytics solution licensed from Montefiore Medical Center (discussed in Note 12 – Commitments and Contingencies).

Following the modification of the Royalty Agreement in the second quarter of fiscal 2018 (discussed in Note 12 – Commitments and Contingencies), the royalty liability was significantly reduced as a result of the commitment to fulfill a portion of our obligation by providing incremental maintenance services. The fair value of the royalty liability was determined based on the portion of the modified royalty commitment payable in cash.

Schedule of Impact of Adoption of New Accounting Pronouncement

 

 

Year Ended January 31, 2019

 

    

As reported under
ASC 606

    

Balances without
adoption of
ASC 606

    

Adjustments due to
ASC 606

Revenues

 

 

 

 

 

 

 

 

 

Systems sales

 

$

2,472,000

 

$

2,322,000

 

$

150,000

Maintenance and support

 

 

12,586,000

 

 

12,590,000

 

 

(4,000)

 

 

 

 

 

 

 

 

 

 

 

 

 

As of January 31, 2019

 

    

As reported under
ASC 606

    

Balances without
adoption of
Topic 606

    

Adjustments due to
ASC 606

Assets

 

 

 

 

 

 

 

 

 

Contract receivables, current

 

$

1,263,000

 

$

803,000

 

$

460,000

Contract receivables, noncurrent

 

 

407,000

 

 

27,000

 

 

380,000

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Deferred revenues, current

 

 

8,338,000

 

 

9,084,000

 

 

(746,000)

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

 

 

Accumulated deficit

 

$

(76,550,000)

 

$

(78,136,000)

 

$

1,586,000

 

Schedule of Disaggregated Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended January 31, 2019

 

    

Recurring Revenue

    

Non-recurring Revenue

    

Total

Systems sales

 

$

899,000

 

$

1,573,000

 

$

2,472,000

Professional services

 

 

 —

 

 

1,336,000

 

 

1,336,000

Audit services

 

 

 —

 

 

1,118,000

 

 

1,118,000

Maintenance and support

 

 

12,586,000

 

 

 —

 

 

12,586,000

Software as a service

 

 

4,853,000

 

 

 —

 

 

4,853,000

Total revenue:

 

$

18,338,000

 

$

4,027,000

 

$

22,365,000

 

Schedule of Cumulative Effect of Adoption of Accounting Pronouncement

 

 

 

 

 

 

 

 

 

 

 

    

As Reported
January 31, 2018

    

Adjustments
due to ASC 606

    

As Adjusted
February 1, 2018

ASSETS

 

 

 

 

 

 

 

 

 

Contract receivables, current

 

$

224,000

 

$

283,000

 

$

507,000

Contract receivables, noncurrent

 

 

 —

 

 

468,000

 

 

468,000

 

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

Deferred revenues, current

 

 

9,482,000

 

 

(689,000)

 

 

8,793,000

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

Accumulated deficit

 

$

(72,125,000)

 

$

1,440,000

 

$

(70,685,000)

 

Schedule of Earnings Per Share, Basic and Diluted

 

 

 

 

 

 

 

 

 

Fiscal Year

 

 

2018

    

2017

Net earnings (loss)

 

$

(5,865,000)

 

$

(3,099,000)

Weighted average shares outstanding - Basic

 

 

19,540,980

 

 

19,090,899

Stock options, Restricted stock and Series A Convertible Preferred Stock

 

 

 

 

Weighted average shares outstanding - Diluted

 

 

19,540,980

 

 

19,090,899

Basic net earnings (loss) per share of common stock

 

$

(0.30)

 

$

(0.16)

Diluted net earnings (loss) per share of common stock

 

$

(0.30)

 

$

(0.16)